Dublin, April 21, 2022 (GLOBE NEWSWIRE) -- The "Oxygen Long Term COVID-19 Treatments Address Pulmonary Arterial Vascular Degeneration: Treatment with Portable Oxygen Concentrators" report from Wintergreen Research, Inc has been added to ResearchAndMarkets.com's offering. Exercise intolerance is responsive to intermittent supplemental oxygen. Oxygen treatments represent next generation automation of helping people who are challenged by exercise. The oxygen market has a CAGR of 17.4%.
Exercise intolerance is a side effect of long term COVID, often a diagnosis for those who have unusual fatigue who have been tested by a physician and determined to have no verifiable signs of disease, yet they are still disabled. The problem is frequently a lack of oxygen that impacts the blood flow between organs, between the heart and the lungs. Until now, the diagnosis has been hard to achieve. It has been discovered that the spikes on the virus do subtle vascular damage that is only apparent when the person exercise strenuously. Mostly it appears that the subtle damage can be repaired with diet, exercise, oxygen, and good nutrition. This is expected to further stimulate oxygen markets as studies demonstrate the efficacy of various treatment regimes. Key Topics Covered: Exercise Intolerance - Oxygen Concentrator Executive Summary
Long Term COVID Patients Benefit from Treatment with Intermittent Supplemental Oxygen
Fatigue, Shortness of Breath Upon Exertion Treated with Oxygen:
Portable Oxygen Concentrator Market Shares
Portable Oxygen Concentrator Market Forecasts
1. Exercise Intolerance: Portable Oxygen Concentrator Market Description and Market Dynamics 1.1 Diagnosing and Treating People with Fatigue, People Who Are Challenged by Exercise 1.2 Pulmonary Arterial Hypertension (PAH), High Blood Pressure in the Lungs, Characterized by Exercise Intolerance 1.3 Oxygen Concentrator Uses 1.4 Oxygen Concentrator Insurance Coverage 1.5 Portable Oxygen Concentrator for Exercise Intolerance 2 Oxygen Long Term Treatment Market Driving Forces 2.1 Oxygen Long Term Treatment 2.2 Exercise Intolerance Cardio-Pulmonary Portable Oxygen Concentrator Market Shares: 2.3 Portable Oxygen Concentrator Forecasts 2.4 Research White Paper: Supplemental Oxygen 2.5 Stationary Oxygen Concentrators 2.6 High Flow Oxygen Concentrators 2.7 Hyperbaric Oxygen HBOT 2.8 Exercise Intolerance Equipment Market Forecasts 2.9 Worldwide Patients on Oxygen Market Forecasts, Worldwide, 2021-2028 2.10 Portable Oxygen Concentrator Prices 2.11 Portable Oxygen Concentrator Regional Market Analysis 3. Exercise Intolerance Portable Oxygen Concentrator for Heart Failure Market Dynamics 3.1 Chronic Fatigue and Long Term Covid 3.2 Portable Oxygen Concentrator 3.3 Chronic Fatigue Syndrome Recognized as a Disability Qualifying for Reimbursement 4. Types of Oxygen Systems 4.1 Oxygen Concentrator Applicable Population 4.2 Types of Oxygen Systems 4.3 Oxygen Concentrator Air Management 4.3.1 Comparison of Conventional Oxygen Concentrators and Advanced Technology Fractionators 4.4 Pressure Swing Adsorption Principles 5 Portable Oxygen Equipment Company Description 5.1 Applied Home Healthcare Equipment 5.2 Besco 5.3 Chart Industries 5.4 Drive - DeVilbiss Healthcare 5.5 First Class Medical 5.6 Foshan Keyhub Electronic Industries Co., Ltd. 5.7 Gardner Denver / Thomas Compressors 5.8 GSE 5.9 Inogen 5.10 Invacare 5.11 Jiuxin Medical 5.12 Leistung Engineering 5.13 Longfian Scitech 5.14 Merits 5.15 Nidek Medical 5.16 NTK 5.17 Precision Medical 5.18 O2 Concepts 5.19 Oxygo 5.20 Philips Healthcare 5.21 ResMed 5.22 Teijin Group 5.23 Zadro Health Solutions 5.24 Oxygen Concentrator Companies Companies Mentioned
Foshan Keyhub Electronic Industries Co., Ltd.
Jiuxin Medical Jogger Portable Ventilator
Jiuxin Medical ICU Ventilator Detachable 10.4"TFT Color Screen
Philips Respironics Portable Oxygen Concentrator
Royal Philips Healthcare Global Presence
For more information about this report visit https://www.researchandmarkets.com/r/gsp322 Source: Wintergreen Research, Inc
About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
(Bloomberg) -- Novavax Inc. slumped 20% on Friday after US regulators raised concerns over the biotech’s much-anticipated Covid-19 vaccine. Most Read from BloombergOne-Third of Americans Making $250,000 Live Paycheck-to-Paycheck, Survey FindsTesla Pauses Hiring as Musk Aims for 10% Staff Cut, Reuters SaysElon Musk’s Ultimatum to Tesla Execs: Return to the Office or Get Out‘Most Clever Oligarch’ Severed His $37 Billion Fortune From Russian RootsApple Plans to Make the iPad More Like a Laptop and
The FDA suggested Friday there could be a link between Novavax's Covid vaccine and heart inflammation, and NVAX stock plummeted.
These big names are down — but certainly not out.
In the world of stock legends, Ken Fisher stands out. The legendary investor founded his private financial advisory firm, Fisher Investments, in 1979, with just $250 in seed money. Today, Fisher’s company manages over $195 billion in total assets, and his personal net work exceeds $5 billion. Fisher has cast his eye on current market conditions. In recent published note, Fisher points out the obvious headwinds in the current environment: “Fear of the impact of the tragic, grinding war in Ukraine
U.S. Labor Secretary Marty Walsh says it's time for his new billionaire acquaintance Elon Musk to give him another phone call as the Tesla CEO eyes mass layoffs at the EV maker.
U.S. Food and Drug Administration staff said on Friday Novavax Inc's vaccine reduces the risk of mild-to-severe COVID-19 and that it was likely the shot could provide some level of protection against the Omicron variant. The FDA analyzed data from Novavax's trial before the Omicron and Delta variant became the dominant strains. "Based on the efficacy estimate in the clinical trial of this vaccine, it is more likely than not that the vaccine will provide some meaningful level of protection against COVID-19 due to Omicron, in particular against more severe disease," FDA staff said.
Semiconductor specialist Nvidia (NASDAQ: NVDA) was down as much as 5.5%, iPhone maker Apple (NASDAQ: AAPL) was off by as much as 4.5%, and e-commerce kingpin Amazon (NASDAQ: AMZN) slipped as much as 3.5%. New warnings about the possibility of a recession sent a wide swath of stocks lower today, but there was also company-specific news for each of the technology stalwarts. Tesla CEO Elon Musk joined the chorus of business leaders sounding the alarm about the economy and the possibility of a recession.
Piper Sandler is scared of a computer memory glut, but Micron's stock price is cheap enough to already factor that in.
Don’t bail on stocks. Just choose them wisely.
One of the proposed shareholder measures, which was expected to be rubber-stamped by investors, has hit some surprising resistance.
(Bloomberg) -- Mark Spitznagel is paid to be prepared for when the market’s weakest links are exposed in a big way.Most Read from BloombergOne-Third of Americans Making $250,000 Live Paycheck-to-Paycheck, Survey FindsTesla Pauses Hiring as Musk Aims for 10% Staff Cut, Reuters SaysElon Musk’s Ultimatum to Tesla Execs: Return to the Office or Get Out‘Most Clever Oligarch’ Severed His $37 Billion Fortune From Russian RootsApple Plans to Make the iPad More Like a Laptop and Less Like a PhoneRight no
Elon Musk stole the spotlight this morning, and his reported comments are hitting the stock prices of many electric vehicle (EV) makers. Nio (NYSE: NIO) is one that shares the Chinese market with Musk's Tesla, and its American depositary shares are being impacted. As of 11:06 a.m. ET, Nio shares were down 4.9% on the final trading day of the week.
Tesla CEO Elon Musk's "super bad feeling" about the economy could be the auto industry's "canary in the coal mine" moment, signaling a recession for an industry whose bosses have shown no signs of concern. Musk said the electric carmaker needed to cut about 10% of its workforce in an email to executives seen by Reuters. Musk's warning is the first loud and public dissent in a united stance by the auto industry that underlying demand for cars and trucks remains strong despite two years of global pandemic.
(Bloomberg) -- China has sentenced a former Communist Party city chief and securities regulator to death with a two-year reprieve for bribery and insider trading, state broadcaster CCTV reported.Most Read from BloombergOne-Third of Americans Making $250,000 Live Paycheck-to-Paycheck, Survey FindsTesla Pauses Hiring as Musk Aims for 10% Staff Cut, Reuters SaysElon Musk’s Ultimatum to Tesla Execs: Return to the Office or Get OutApple Plans to Make the iPad More Like a Laptop and Less Like a PhoneU
Yahoo Finance Live anchors discuss Sycamore and Franchise Group becoming the latest to submit bids for Kohl’s.
For several months now, relations between the Democratic Party president and the tech tycoon have been at their worst. The bone of contention: Tesla's chief executive blames the Biden administration for ignoring Tesla as it celebrates the auto industry's transformation to electric vehicles. Musk does not understand why Biden puts forward GM , Ford and others in this transformation and forgets Tesla, which is by far the world's leading EV manufacturer.
Novavax Inc.’s (NASDAQ: NVAX) stock tanked more than 20% Friday afternoon after the Food and Drug Administration shared concerns about a potential connection between heart inflammation and the company’s experimental Covid-19 vaccine, which the agency expects to take into consideration next week for potential emergency use authorization. As part of a briefing released Friday, the FDA said its vaccines advisory committee will meet Tuesday to discuss the Gaithersburg company's submission and “provide recommendations on whether, based on the totality of scientific evidence available, the benefits of the Novavax Covid-19 Vaccine 2-dose primary series outweigh its risks for use in individuals 18 years of age and older.” The risks, according to the documents, namely include the potential for inflammation in and around the heart, known as myocarditis and pericarditis.
U.S. stocks dropped Friday as investors weighed hot May jobs data that likely gave a nod to Fed policymakers labor market conditions could weather a more aggressive rate hiking cycle.
Amazon stock is working on its sixth straight daily rally ahead of its 20-for-1 stock split. Here's what the charts say now.
In this article, we will take a look at the 11 stocks in focus after releasing their earnings reports. You can skip our detailed analysis of these companies and go directly to the 5 Stocks in Focus After Releasing Their Earnings Reports. Recently, popular tech stocks, including Salesforce, Inc. (NYSE:CRM), NetApp, Inc. (NASDAQ:NTAP) and Pure […]